A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps

Clinical trial NCT03280537 · COMPLETED

Trial details

NCT number: NCT03280537
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Nasal Polyps Chronic Rhinosinusitis

Start date: 2017-11-21
Primary completion: 2019-03-07
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.